drug

Guanfacine/Tenex

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Research Foundation for Mental Hygiene, Inc.
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
NCT00469664Phase 4Unknown

KOLs & investigators

1
Joseph I. Friedman, MDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Research Foundation for Mental Hygiene, Inc.
company
trial
Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
PHASE4
trial
indication
Schizophrenia
indication
Cognitive Impairment
indication
Schizophrenia
indication
Cognitive Dysfunction
indication
KOL
Joseph I. Friedman, MD
KOL score 5
person